Key Points
- Biomarker and proteomics specialist Altheome has relocated to Motherlabs at Advanced Research Clusters (ARC) West London.
- The company has secured over 1,600 square feet (SQF) of fitted laboratory space in Hammersmith.
- Altheome focuses on discovering and measuring biological indicators (biomarkers) in blood and tissues to improve the understanding of health and disease.
- ARC’s Motherlabs Accelerator provides fitted laboratory space, shared services, and a dedicated lab manager for growing science firms.
- Key leadership figures involved include Alex Lowdell (Leasing Associate Director at ARC) and Adam Shellard (Founder and CEO at Altheome).
- ARC West London is part of the wider WestTech London innovation network supporting regional life sciences growth.
uk/local/hammersmith-and-fulham/hammersmith/">Hammersmith, West London (West London Times) October 22, 2026 — Altheome has relocated to Motherlabs at Advanced Research Clusters (ARC) West London, securing more than 1,600 square feet of fitted laboratory space to support its biomarker discovery and proteomics research. The move strengthens the campus’s life sciences ecosystem by providing Altheome with specialised laboratory facilities, shared services and opportunities for collaboration, supporting the development of precision medicine and the wider growth of West London’s innovation sector.
What are the key details of Altheome’s relocation to ARC West London?
As reported by Mike Lightfoot of UK Property Forums, Altheome—a specialist in biomarkers and proteomics dedicated to advancing precision medicine through advanced analytical platforms—has completed its move into Motherlabs at ARC West London. The company has taken over 1,600 square feet of fitted laboratory space tailored specifically for biotechnology and life sciences enterprises.
Altheome’s core operational focus centres on identifying and measuring biomarkers, which are critical biological indicators found in blood and tissues. These indicators enable researchers and clinicians to gain deeper insights into human health and disease pathways, paving the way for targeted medical interventions and diagnostic advancements.
Why did Altheome choose ARC West London’s Motherlabs?
Located within ARC’s West London campus in Hammersmith, the Motherlabs Accelerator is specifically designed to support scaling science and technology companies. It provides fully fitted laboratory environments, comprehensive shared services, and a dedicated on-site lab manager to streamline day-to-day research operations.
As reported by Mike Lightfoot of UK Property Forums, Adam Shellard, founder and CEO at Altheome, highlighted the significance of the new facility, stating that
“Having the right laboratory environment is important as we continue to develop our capabilities in biomarker discovery and proteomics. Motherlabs offers the fitted space and shared services we need, alongside the opportunity to connect with other innovative life sciences businesses and build collaborations that can help advance precision medicine.”
Who are the key figures and organizations involved in this life sciences expansion?
The relocation underscores the expanding collaborative network within ARC West London, which hosts a diverse community of life sciences and innovation-led organisations. Notable tenant companies sharing the campus include Kesmalea, Sania Therapeutics, GENinCode, Epsilogen, and Econic Biosciences.
The campus is structured to accommodate businesses across all stages of growth. Organizations can scale from a single bench in Leap—an incubator space operated in partnership with the Imperial Incubator—all the way up to established multinational corporations.
As reported by Mike Lightfoot of UK Property Forums, Alex Lowdell, leasing associate director at ARC, welcomed the new tenant by stating that
“We’re delighted to welcome Altheome into the thriving life sciences ecosystem at ARC West London. Their move is a great example of the specialist businesses we’re looking to support, providing the fitted laboratory space and shared services they need to develop their technologies and advance their research.”
What role does WestTech London play in the region’s innovation ecosystem?
ARC West London operates as an integral component of WestTech London, a collaborative network of regional stakeholders dedicated to unlocking the full potential of the area’s innovation landscape.
Capitalising on world-class universities and research institutions, a diverse talent pool, rich industrial heritage, and major transport links connecting to both the UK and international markets, WestTech London aims to foster a robust economic ecosystem. The overarching mission of the network is to generate high-value jobs, attract sustained investment, and drive inclusive economic growth across West London.
Background of Precision Medicine and ARC West London Development
The growth of specialised hubs like ARC West London’s Motherlabs reflects a broader structural evolution in the UK life sciences sector. Over recent years, demand for fitted, flexible laboratory space has surged as early-stage biotechnology and proteomics startups seek to bypass the high capital expenditure traditionally required to build and maintain wet-lab facilities. By offering turnkey laboratory infrastructure alongside shared support services, accelerator facilities such as Motherlabs lower barriers to entry for research-intensive firms. Precision medicine—which tailors medical treatment to the individual characteristics of each patient—relies heavily on advanced biomarker discovery, making access to state-of-the-art analytical platforms and collaborative research clusters an essential catalyst for commercial and scientific breakthroughs in Greater London.
Explore more Hammersmith News:
Hammersmith Conservatives Walk Out After Finance Debate Rejection In Hammersmith 2026
NHS Launches Cardiac Clinical Trial to Improve Heart Care Hammersmith 2026
How This Development Affects Industry Stakeholders and the Local Economy
This expansion is expected to generate positive ripple effects across the West London innovation corridor. For local biotechnology startups, spin-outs, and life sciences researchers in Hammersmith, Altheome’s integration into Motherlabs reinforces the density of collaborative networks, increasing the likelihood of cross-sector partnerships between proteomics firms, clinical researchers, and diagnostic developers. For investors and commercial real estate stakeholders in the UK life sciences market, continued leasing momentum at ARC West London validates the strong demand for specialized, fitted laboratory assets over traditional commercial office space. Ultimately, as networks like WestTech London continue to scale, this development contributes to regional job creation, attracts venture capital into British life sciences, and accelerates the translational pipeline from laboratory discovery to patient-ready precision therapeutics.
